In today’s recent session, 0.76 million shares of the Abbvie Inc (NYSE:ABBV) have been traded, and its beta is 0.50. Most recently the company’s share price was $189.1, and it changed around -$0.67 or -0.35% from the last close, which brings the market valuation of the company to $334.02B. ABBV at last check was trading at a discount to its 52-week high of $218.66, offering almost -15.63% off that amount. The share price’s 52-week low was $163.81, which indicates that the recent value has risen by an impressive 13.37% since then. We note from Abbvie Inc’s average daily trading volume that its 10-day average is 8.25 million shares, with the 3-month average coming to 7.39 million.
Abbvie Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.87. If we narrow it down even further, the data shows that 0 out of 28 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 12 recommended ABBV as a Hold, whereas 12 deemed it a Buy, and 0 rated it as Underweight.
Abbvie Inc (NYSE:ABBV) trade information
Instantly ABBV has been showing red trend so far today with a performance of -0.35% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 193.00 on recent trading dayincreased the stock’s daily price by 2.02%. The company’s shares are currently up 13.06% year-to-date, but still down -0.47% over the last five days. On the other hand, Abbvie Inc (NYSE:ABBV) is -0.39% down in the 30-day period. We can see from the shorts that 14.7 million shares have been sold at a short interest cover period of 2.5 day(s).
The consensus price target as assigned by Wall Street analysts is $217.5, which translates to bulls needing to increase their stock price by 13.06% from its current value. Analyst projections state that ABBV is forecast to be at a low of $215 and a high of $220.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -14.67%. Abbvie Inc earnings are expected to increase by 20.13% in 2025, but the outlook is positive 15.22% per year for the next five years.
ABBV Dividends
Abbvie Inc’s next quarterly earnings report is expected to be released on 2025-Apr-25. The annual dividend yield of the stock is 3.37 percent and its annual dividend per share was 6.38. It is important to note, however, that the 3.37% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 3.91 per year.
Abbvie Inc (NYSE:ABBV)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.10% of Abbvie Inc shares, and 74.40% of them are in the hands of institutional investors. The stock currently has a share float of 74.47%. Abbvie Inc stock is held by 4632.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.6472% of the shares, which is about 170.66 million shares worth $29.27 billion.
BLACKROCK INC., with 7.7124% or 136.43 million shares worth $23.4 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 55.77 shares worth $10.56 billion, making up 3.16% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard 500 Index Fund held roughly 49.05 shares worth around $9.28 billion, which represents about 2.78% of the total shares outstanding.
